KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Deferred Taxes (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Deferred Taxes for 11 consecutive years, with $17.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 171.93% year-over-year to $17.4 million, compared with a TTM value of $80.8 million through Dec 2025, up 403.29%, and an annual FY2025 reading of $80.8 million, up 403.29% over the prior year.
  • Deferred Taxes was $17.4 million for Q4 2025 at Medpace Holdings, down from $28.5 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $34.1 million in Q2 2025 and bottomed at -$40.4 million in Q4 2021.
  • Average Deferred Taxes over 5 years is -$1.6 million, with a median of -$719500.0 recorded in 2022.
  • The sharpest move saw Deferred Taxes crashed 1006.11% in 2023, then surged 63261.11% in 2025.
  • Year by year, Deferred Taxes stood at -$40.4 million in 2021, then surged by 48.31% to -$20.9 million in 2022, then surged by 33.89% to -$13.8 million in 2023, then plummeted by 75.24% to -$24.2 million in 2024, then soared by 171.93% to $17.4 million in 2025.
  • Business Quant data shows Deferred Taxes for MEDP at $17.4 million in Q4 2025, $28.5 million in Q3 2025, and $34.1 million in Q2 2025.